18+ Adults only. We do not sell to anyone under 18. Research compounds are supplied for research use only.

Peptides for Weight Loss

Weight-loss peptides work on the hormones that control hunger, so smaller meals feel like enough and cravings fade into the background. This page compares retatrutide, tirzepatide, semaglutide and tesamorelin on what their trials actually showed, what each costs per dose, and whether a ready-to-use pen or a better-value self-mix vial suits you.

The short version

  • Strongest result so far: retatrutide, three hormone signals instead of one or two, and the largest average weight loss of the group in trials.
  • Proven all-rounder: tirzepatide, with two hormone signals and large phase 3 trials behind it.
  • Gentlest start: semaglutide, the original GLP-1 with the longest track record.
  • Stubborn belly fat: tesamorelin, which targets the deep fat around your middle.
  • Two in one vial: blends such as Tirreta, T-Ret, Tirsema and Cagrisema pair two compounds, so you mix and inject once.
  • All of them are once a week (tesamorelin is daily) and start low, stepping up every 4 weeks.

What the trials showed

These are the headline results from the main published trial for each peptide, on the highest dose tested. They are averages from controlled studies, where people also had diet and activity advice, so individual results vary.

PeptideHow it worksHow oftenMain trial result
RetatrutideGLP-1, GIP and glucagon signalsOnce a week24.2% average weight loss at 48 weeks, in a phase 2 trial
TirzepatideGLP-1 and GIP signalsOnce a week20.9% average weight loss at 72 weeks
SemaglutideGLP-1 signalOnce a week14.9% average weight loss at 68 weeks
TesamorelinBoosts your own growth hormoneOnce a dayAbout 15% less deep belly (visceral) fat at 26 weeks, in adults with HIV-related belly fat

One caveat on the top row. Retatrutide’s figure comes from a phase 2 trial, which was smaller and shorter than the phase 3 trials behind tirzepatide and semaglutide. Read it as promising rather than settled.

Cagrilintide works on amylin, a different hunger signal again, and we stock it paired with semaglutide as Cagrisema. It is the newest of the group and its large trial results are still coming through, so we have not put a headline number beside it.

Sources are listed at the end of this page.

Everything we stock for weight loss

Strengths and formats move with stock. These are the compound families, with the price comparison page for each where there is one.

See every weight-loss product, or try the peptide finder if you would rather answer a few questions.

Our top picks

Retatrutide 64mg Double Strength

Three signals rather than two, and the largest average weight loss of any of these in trials. Double strength means one vial carries twice the milligrams.

Tirzepatide 60mg Double Strength Pen (Noventra Pharma)

Dual-action GLP-1 and GIP, with around 21% weight loss in its main trial. Double strength means one pen goes twice as far.

iZempic 5mg Pen (iPharma)

Semaglutide, the peptide that started it all. A gentle, slow build-up makes it the easiest place to start if you have never used a GLP-1.

Tesamorelin 2mg (UPA Labs)

The specialist for belly fat. In human trials it cut deep visceral fat by around 15% in six months, and it works by boosting your own growth hormone rather than suppressing appetite.

What it costs per dose

Prices per pen or vial are hard to compare, because each holds a different amount. Per dose is fairer, and these figures update with our live prices and stock:

Self-mix vials are usually the cheaper way in. Pens cost a little more for the convenience of click dosing with nothing to mix.

How to choose

Start with the peptide, then pick the format. Retatrutide has the largest trial result so far, tirzepatide is the proven all-rounder with the biggest body of phase 3 evidence, and semaglutide is the gentle first step. Tesamorelin is different: it does not touch appetite, so it is often run alongside one of the others.

Blends suit someone who wants two compounds without two injections. The trade-off is that the milligrams are shared between them, so a 60mg blend is not 60mg of either one.

Pens are ready to use and click-dosed. Self-mix vials cost less per milligram but you mix them yourself, which takes about a minute (see our mixing guide).

Getting the most from it

The peptide does most of the work on appetite. What you do around it decides how much of the weight lost is fat rather than muscle, and whether the result holds.

  • Protein and lifting. Part of the weight lost on these peptides is lean mass. Enough protein and regular resistance training are the best-supported ways to protect it.
  • Go slowly at first. Nausea is most common in the first weeks and after each step up.
  • Beyond GLP-1s. AOD-9604, 5-Amino-1MQ, SLU-PP-332 and MOTS-c work through other routes, with lighter evidence behind them. Fat-loss peptides that are not GLP-1s goes through each one.

Tools that help

Questions

Which peptide is best for weight loss?

In their main trials, retatrutide produced around 24% average weight loss, tirzepatide around 21% and semaglutide around 15%. Retatrutide’s figure rests on a phase 2 trial, so there is less evidence behind it than the other two. Tesamorelin works differently again and targets deep belly fat. The best fit depends on your goal and your budget.

What is the difference between retatrutide and tirzepatide?

Tirzepatide acts on two hormone receptors, GLP-1 and GIP. Retatrutide adds a third, glucagon. In trials that third signal came with more weight loss, but retatrutide has only phase 2 results so far against tirzepatide’s phase 3.

Do you stock anything that is not a GLP-1?

Yes. AOD-9604, 5-Amino-1MQ, SLU-PP-332, MOTS-c and HGH Fragment 176-191 act on fat metabolism rather than appetite, and the evidence behind them is lighter than the GLP-1 trials. Our guide to fat-loss peptides that are not GLP-1s goes through each one.

How quickly does the weight come off?

Gradually. In the main retatrutide, tirzepatide and semaglutide trials, weight loss built up over 48 weeks or more. The first weeks are slower because the dose starts low.

How much does it cost per week?

Retatrutide currently starts from R74 for a 2mg dose and tirzepatide from R85 for 2.5mg. The cost rises as the dose steps up, so our price pages work it out per milligram for every option.

Is a pen or a vial better for weight loss?

Both contain the same peptide. A pen is ready to use with click dosing, while a self-mix vial is cheaper per milligram and takes about a minute to mix with the bacteriostatic water that comes with most vials.

How often do you inject weight-loss peptides?

Retatrutide, tirzepatide and semaglutide are once a week, ideally on the same day. Tesamorelin is once a day. All of them start at a low dose and step up gradually.

Will I lose muscle?

Some of the weight lost on these peptides is lean mass, as with any large weight loss. Eating enough protein and doing regular resistance training are the best-supported ways to keep more of it.

What are the common side effects?

Nausea is the most common, mostly in the first weeks and after stepping up a dose. Smaller meals and plenty of water help. Each product page lists what to watch for.

Keep reading

Sources

  • Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine, 2023. doi.org/10.1056/NEJMoa2301972
  • Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022. doi.org/10.1056/NEJMoa2206038
  • Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021. doi.org/10.1056/NEJMoa2032183
  • Falutz J et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine, 2007. doi.org/10.1056/NEJMoa072375

All products are sold for research use only.

Related reading: fat burners vs peptides for weight loss and slimming injections in South Africa.

Other goals

← All goals